| homeostasis of number of cells | GO:0048872 | 210 | 0.302 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.180 | |
| spermatogenesis | GO:0007283 | 284 | 0.141 | |
| gland development | GO:0048732 | 330 | 0.130 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.126 | |
| cell adhesion | GO:0007155 | 329 | 0.116 | |
| regionalization | GO:0003002 | 337 | 0.113 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.079 | |
| developmental maturation | GO:0021700 | 193 | 0.078 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.074 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.074 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.071 | |
| gonad development | GO:0008406 | 141 | 0.066 | |
| dna repair | GO:0006281 | 107 | 0.061 | |
| skeletal system development | GO:0001501 | 356 | 0.058 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.057 | |
| male gamete generation | GO:0048232 | 285 | 0.057 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.054 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.054 | |
| placenta development | GO:0001890 | 140 | 0.053 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.052 | |
| dna metabolic process | GO:0006259 | 303 | 0.051 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.051 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.051 | |
| negative regulation of cell size | GO:0045792 | 3 | 0.050 | |
| regulation of defense response | GO:0031347 | 233 | 0.049 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.049 | |
| cation transport | GO:0006812 | 399 | 0.048 | |
| notch signaling pathway | GO:0007219 | 71 | 0.047 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.046 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.045 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.043 | |
| stem cell development | GO:0048864 | 219 | 0.042 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.042 | |
| methylation | GO:0032259 | 134 | 0.042 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.042 | |
| response to uv | GO:0009411 | 44 | 0.041 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.041 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.041 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.040 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.040 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.039 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.039 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.039 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.038 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.038 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.036 | |
| digestive tract development | GO:0048565 | 190 | 0.036 | |
| skin development | GO:0043588 | 220 | 0.035 | |
| compound eye development | GO:0048749 | 1 | 0.035 | |
| translation | GO:0006412 | 93 | 0.034 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.034 | |
| protein ubiquitination | GO:0016567 | 171 | 0.034 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.033 | |
| protein localization to organelle | GO:0033365 | 185 | 0.033 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.033 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.032 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.032 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.032 | |
| stem cell differentiation | GO:0048863 | 268 | 0.032 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.031 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.031 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.030 | |
| protein maturation | GO:0051604 | 176 | 0.030 | |
| forebrain development | GO:0030900 | 302 | 0.030 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.030 | |
| cell fate commitment | GO:0045165 | 210 | 0.029 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.029 | |
| spermatid development | GO:0007286 | 108 | 0.029 | |
| lateral inhibition | GO:0046331 | 1 | 0.029 | |
| muscle tissue development | GO:0060537 | 308 | 0.029 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.029 | |
| bone development | GO:0060348 | 120 | 0.029 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.029 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.028 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.028 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.028 | |
| protein catabolic process | GO:0030163 | 221 | 0.028 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.028 | |
| digestive system development | GO:0055123 | 200 | 0.027 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.027 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.027 | |
| peptide secretion | GO:0002790 | 114 | 0.027 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.027 | |
| mapk cascade | GO:0000165 | 281 | 0.027 | |
| innate immune response | GO:0045087 | 157 | 0.027 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.026 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.026 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.026 | |
| gastrulation | GO:0007369 | 116 | 0.026 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.025 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.025 | |
| oocyte axis specification | GO:0007309 | 2 | 0.025 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.025 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.025 | |
| response to oxidative stress | GO:0006979 | 123 | 0.025 | |
| histone modification | GO:0016570 | 159 | 0.024 | |
| dendrite development | GO:0016358 | 115 | 0.024 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.024 | |
| negative regulation of synaptic vesicle transport | GO:1902804 | 3 | 0.024 | |
| dorsal ventral axon guidance | GO:0033563 | 3 | 0.024 | |
| response to radiation | GO:0009314 | 165 | 0.024 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.024 | |
| glycosylation | GO:0070085 | 62 | 0.024 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.023 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.023 | |
| epidermis development | GO:0008544 | 187 | 0.023 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.023 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.023 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.023 | |
| hormone secretion | GO:0046879 | 128 | 0.023 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.022 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.022 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.022 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.022 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.022 | |
| amine metabolic process | GO:0009308 | 45 | 0.022 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.022 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.022 | |
| neural tube closure | GO:0001843 | 90 | 0.022 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.022 | |
| respiratory system development | GO:0060541 | 190 | 0.022 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.022 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.022 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.022 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.022 | |
| response to inorganic substance | GO:0010035 | 96 | 0.022 | |
| organelle fission | GO:0048285 | 170 | 0.021 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.021 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.021 | |
| cellular response to peptide | GO:1901653 | 92 | 0.021 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.021 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.021 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.021 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.021 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.021 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.021 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.021 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.021 | |
| cell recognition | GO:0008037 | 83 | 0.021 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.021 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.020 | |
| regulation of secretion | GO:0051046 | 274 | 0.020 | |
| segmentation | GO:0035282 | 93 | 0.020 | |
| t cell activation | GO:0042110 | 289 | 0.020 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.020 | |
| oxidation reduction process | GO:0055114 | 342 | 0.020 | |
| macromolecule methylation | GO:0043414 | 120 | 0.020 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.020 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.020 | |
| chromatin modification | GO:0016568 | 187 | 0.020 | |
| spinal cord development | GO:0021510 | 81 | 0.019 | |
| respiratory tube development | GO:0030323 | 167 | 0.019 | |
| molting cycle | GO:0042303 | 90 | 0.019 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.019 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.019 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.019 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.019 | |
| cell maturation | GO:0048469 | 127 | 0.019 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.019 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.019 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.019 | |
| regulation of antimicrobial peptide biosynthetic process | GO:0002805 | 1 | 0.019 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.018 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.018 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.018 | |
| cell division | GO:0051301 | 120 | 0.018 | |
| oocyte construction | GO:0007308 | 2 | 0.018 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.018 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.018 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.018 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.018 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.018 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.018 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.018 | |
| nuclear division | GO:0000280 | 158 | 0.018 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.018 | |
| germ cell development | GO:0007281 | 185 | 0.018 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.018 | |
| camera type eye development | GO:0043010 | 266 | 0.018 | |
| neuron death | GO:0070997 | 154 | 0.017 | |
| b cell activation | GO:0042113 | 161 | 0.017 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.017 | |
| appendage development | GO:0048736 | 166 | 0.017 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.017 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.017 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.017 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.017 | |
| hindbrain development | GO:0030902 | 128 | 0.017 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.017 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.017 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.017 | |
| cell fate determination involved in pattern specification | GO:0060582 | 1 | 0.017 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.017 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.016 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.016 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.016 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.016 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.016 | |
| primary neural tube formation | GO:0014020 | 95 | 0.016 | |
| epithelial tube formation | GO:0072175 | 130 | 0.016 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.016 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.016 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.016 | |
| regulation of binding | GO:0051098 | 111 | 0.016 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.016 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.016 | |
| locomotory behavior | GO:0007626 | 195 | 0.016 | |
| rna processing | GO:0006396 | 105 | 0.016 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.016 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.016 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.016 | |
| response to steroid hormone | GO:0048545 | 56 | 0.016 | |
| apical constriction | GO:0003383 | 4 | 0.016 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.016 | |
| multicellular organism growth | GO:0035264 | 161 | 0.016 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.016 | |
| endocytosis | GO:0006897 | 168 | 0.015 | |
| protein processing | GO:0016485 | 163 | 0.015 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.015 | |
| regulation of cell shape | GO:0008360 | 39 | 0.015 | |
| insulin secretion | GO:0030073 | 89 | 0.015 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.015 | |
| somitogenesis | GO:0001756 | 69 | 0.015 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.015 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.015 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.015 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.015 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.015 | |
| regulation of protein localization | GO:0032880 | 231 | 0.014 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.014 | |
| trunk segmentation | GO:0035290 | 4 | 0.014 | |
| neuron projection guidance | GO:0097485 | 141 | 0.014 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.014 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.014 | |
| regulation of notch signaling pathway | GO:0008593 | 35 | 0.014 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.014 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.014 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.014 | |
| response to insulin | GO:0032868 | 100 | 0.014 | |
| negative regulation of synaptic vesicle exocytosis | GO:2000301 | 3 | 0.014 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.014 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.014 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.014 | |
| peptide transport | GO:0015833 | 133 | 0.014 | |
| cellular response to epidermal growth factor stimulus | GO:0071364 | 4 | 0.014 | |
| nuclear transport | GO:0051169 | 139 | 0.014 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.014 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.014 | |
| norepinephrine transport | GO:0015874 | 2 | 0.014 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.014 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.014 | |
| regulation of cell motility | GO:2000145 | 236 | 0.014 | |
| metencephalon development | GO:0022037 | 89 | 0.013 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.013 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.013 | |
| transmembrane transport | GO:0055085 | 412 | 0.013 | |
| regulation of acetylcholine secretion neurotransmission | GO:0014056 | 2 | 0.013 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.013 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.013 | |
| cytokine production | GO:0001816 | 319 | 0.013 | |
| response to peptide hormone | GO:0043434 | 127 | 0.013 | |
| neural tube formation | GO:0001841 | 108 | 0.013 | |
| cellular polysaccharide metabolic process | GO:0044264 | 38 | 0.013 | |
| response to growth factor | GO:0070848 | 198 | 0.013 | |
| response to light stimulus | GO:0009416 | 135 | 0.013 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.013 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.013 | |
| exocytosis | GO:0006887 | 121 | 0.013 | |
| photoreceptor cell maintenance | GO:0045494 | 19 | 0.013 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.013 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.013 | |
| cell growth | GO:0016049 | 130 | 0.013 | |
| tube formation | GO:0035148 | 140 | 0.013 | |
| tissue homeostasis | GO:0001894 | 115 | 0.013 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.013 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.013 | |
| urogenital system development | GO:0001655 | 261 | 0.013 | |
| protein glycosylation | GO:0006486 | 55 | 0.013 | |
| formation of organ boundary | GO:0010160 | 1 | 0.013 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.013 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.013 | |
| transition metal ion transport | GO:0000041 | 38 | 0.013 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.012 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.012 | |
| developmental cell growth | GO:0048588 | 84 | 0.012 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.012 | |
| liver development | GO:0001889 | 66 | 0.012 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.012 | |
| activation of immune response | GO:0002253 | 138 | 0.012 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.012 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.012 | |
| b cell differentiation | GO:0030183 | 78 | 0.012 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.012 | |
| protein import | GO:0017038 | 101 | 0.012 | |
| myotube differentiation | GO:0014902 | 105 | 0.012 | |
| actin filament polymerization | GO:0030041 | 44 | 0.012 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.012 | |
| dephosphorylation | GO:0016311 | 129 | 0.012 | |
| mrna metabolic process | GO:0016071 | 84 | 0.012 | |
| negative regulation of epidermal growth factor activated receptor activity | GO:0007175 | 3 | 0.012 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.012 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.012 | |
| response to copper ion | GO:0046688 | 3 | 0.012 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.012 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.012 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.012 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.012 | |
| heart morphogenesis | GO:0003007 | 178 | 0.012 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.012 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.012 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.012 | |
| blastocyst development | GO:0001824 | 80 | 0.011 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.011 | |
| extracellular structure organization | GO:0043062 | 148 | 0.011 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.011 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.011 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.011 | |
| regulation of cell activation | GO:0050865 | 289 | 0.011 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.011 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.011 | |
| cochlea development | GO:0090102 | 35 | 0.011 | |
| limb morphogenesis | GO:0035108 | 149 | 0.011 | |
| neural tube development | GO:0021915 | 160 | 0.011 | |
| stem cell proliferation | GO:0072089 | 117 | 0.011 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.011 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.011 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.011 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.011 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.011 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.011 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.011 | |
| anion transport | GO:0006820 | 177 | 0.011 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.011 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.011 | |
| negative regulation of growth | GO:0045926 | 99 | 0.011 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.011 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.011 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.011 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.011 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.011 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.011 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.011 | |
| leukocyte migration | GO:0050900 | 124 | 0.011 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.011 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.011 | |
| female gamete generation | GO:0007292 | 74 | 0.011 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.010 | |
| chromatin organization | GO:0006325 | 206 | 0.010 | |
| neuromuscular process | GO:0050905 | 99 | 0.010 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.010 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.010 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.010 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.010 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.010 | |
| protein polymerization | GO:0051258 | 57 | 0.010 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.010 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.010 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.010 | |
| regulation of rna export from nucleus | GO:0046831 | 4 | 0.010 | |
| nucleobase containing compound transport | GO:0015931 | 27 | 0.010 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001267 | 4 | 0.010 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.010 | |
| protein targeting | GO:0006605 | 143 | 0.010 | |
| positive regulation of binding | GO:0051099 | 49 | 0.010 | |
| inflammatory response | GO:0006954 | 244 | 0.010 | |
| regulation of lamellipodium assembly | GO:0010591 | 3 | 0.010 | |
